GC Therapeutics (GCTx) is a biopharmaceutical company created to scale and unlock the next generation of cell therapy-based medicines. GCTx's induced pluripotent stem cell (iPSC) programming platform, TFome™ (tee-eff-ome), integrates the latest advancements in synthetic biology, gene editing, cell engineering and machine learning to overcome the therapeutic development and scaling complexities associated with cell therapy and improve patient access across a broad range of disease areas. GCTx's initial focus is on developing first-in-class and best-in-class cell therapies for gastrointestinal, neurological and immunological diseases.

Key Contact

Funding Events

Date	Amount	Type	Investors	Valuation
10/05/24	$65,000,000	Series A	Andreessen Horowitz Cercano Management Cormorant Asset Management Medical Excellence Capital Mubadala Capital Pear Ventures	undisclosed